Published in Hum Pathol on May 01, 1995
Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol (2008) 3.22
Molecular genetic evidence supporting the clonality and appendiceal origin of Pseudomyxoma peritonei in women. Am J Pathol (1999) 2.34
Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg (2007) 2.25
Genome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal origin. Genome Med (2014) 1.55
Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria. Virchows Arch (2016) 1.54
Recent advances in immunohistochemistry in the diagnosis of ovarian neoplasms. J Clin Pathol (2000) 1.38
Pathophysiology and biology of peritoneal carcinomatosis. World J Gastrointest Oncol (2010) 1.07
A specific cadherin phenotype may characterise the disseminating yet non-metastatic behaviour of pseudomyxoma peritonei. Br J Cancer (2006) 0.99
Spectrum of mucin-producing neoplastic conditions of the abdomen and pelvis: cross-sectional imaging evaluation. World J Gastroenterol (2011) 0.98
CT, MRI and PET imaging in peritoneal malignancy. Cancer Imaging (2011) 0.87
Establishment and characterization of a murine xenograft model of appendiceal mucinous adenocarcinoma. Int J Exp Pathol (2010) 0.82
Immunohistochemical and biochemical characterization of mucin in pseudomyxoma peritonei: a case study. Case Rep Gastroenterol (2011) 0.82
Secondary Involvement of the Adnexa and Uterine Corpus by Carcinomas of the Uterine Cervix: A Detailed Morphologic Description. Int J Gynecol Pathol (2015) 0.81
Experience with adjuvant chemotherapy for pseudomyxoma peritonei secondary to mucinous adenocarcinoma of the appendix with oxaliplatin/fluorouracil/leucovorin (FOLFOX4). World J Surg Oncol (2008) 0.81
Outcome of patients with aggressive pseudomyxoma peritonei treated by cytoreductive surgery and intraperitoneal chemotherapy. World J Surg (2013) 0.78
Bevacizumab for the Treatment of Non-Resectable Pseudomyxoma peritonei Associated with Mucinous Ovarian Tumor of Low Malignant Potential - A Comparison of Two Cases. Case Rep Oncol (2009) 0.75
Pseudomyxoma peritonei: disseminated peritoneal adenomucinosis variant. BMJ Case Rep (2011) 0.75
"The Jelly Belly": Diagnostic Dilemmas and Current Concepts. J Obstet Gynaecol India (2016) 0.75
Scalloping of liver in a patient with ascites: pseudomyxoma peritonei. J Clin Exp Hepatol (2013) 0.75
Synchronous primary malignancies of the appendix and ovary causing carcinomatosis in one patient. J Surg Case Rep (2015) 0.75
Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst (1993) 9.48
Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol (1992) 7.14
Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol (1991) 4.62
Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei". Am J Surg Pathol (1995) 4.33
Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol (2004) 4.15
Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases. Am J Surg Pathol (1996) 3.63
Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol (1995) 3.59
Transforming growth factor-beta 1: histochemical localization with antibodies to different epitopes. J Cell Biol (1989) 3.55
The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients. Cancer (1985) 3.50
Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg (1995) 3.41
Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA (1999) 3.37
Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res (1996) 3.00
Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions. J Natl Cancer Inst (1999) 2.98
Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum Pathol (2000) 2.96
A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg (1987) 2.54
Generation of type-specific probes for the detection of single-copy human papillomavirus by a novel in situ hybridization method. Mod Pathol (1998) 2.50
Oncogenic association of specific human papillomavirus types with cervical neoplasia. J Natl Cancer Inst (1987) 2.45
Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding. Br J Surg (2004) 2.33
Epithelioid sarcoma: an immunohistochemical analysis of 112 classical and variant cases and a discussion of the differential diagnosis. Hum Pathol (1999) 2.25
A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis (2000) 2.24
Clinical perspective of human colorectal cancer metastasis. Cancer Metastasis Rev (1984) 2.15
Clear-cell adenocarcinoma of the genital tract in young females. Registry report. N Engl J Med (1972) 2.11
Appendiceal mucocele. Contraindication to laparoscopic appendectomy. Surg Endosc (1998) 2.10
Clinical presentation of the Pseudomyxoma peritonei syndrome. Br J Surg (2000) 2.08
Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol (1999) 2.02
Liposarcoma of the extremities: MR and CT findings in the histologic subtypes. Radiology (1993) 2.01
Pseudomyxoma peritonei syndrome. Adv Surg (1996) 1.99
The pathology of intermediate trophoblastic tumors and tumor-like lesions. Int J Gynecol Pathol (2001) 1.98
A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma. Ann Oncol (2006) 1.96
Epithelioid trophoblastic tumor: a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma. Am J Surg Pathol (1998) 1.93
Quality of life assessment of patients in extremity sarcoma clinical trials. Surgery (1982) 1.86
Perioperative blood transfusions are associated with decreased time to recurrence and decreased survival after resection of colorectal liver metastases. Ann Surg (1988) 1.81
Preoperative laparoscopy in diagnosis of acute abdominal pain. Lancet (1975) 1.78
Effect of physician specialty on outcomes in diabetic ketoacidosis. Diabetes Care (1999) 1.77
Indications for early postoperative intraperitoneal chemotherapy of advanced gastric cancer: results of a prospective randomized trial. World J Surg (2001) 1.77
PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma. Cancer Res (1998) 1.77
Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon. Sex Transm Dis (1993) 1.72
Cofactors with human papillomavirus in a population-based study of vulvar cancer. J Natl Cancer Inst (1997) 1.72
Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance. Int J Gynecol Cancer (2007) 1.70
Gastrointestinal malignancy: rationale for adjuvant therapy using early postoperative intraperitoneal chemotherapy. Br J Surg (1989) 1.70
Characteristics of cell lines established from human colorectal carcinoma. Cancer Res (1987) 1.69
p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis. Am J Pathol (1997) 1.67
Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. Am J Surg Pathol (1996) 1.65
Preoperative localization of focal liver lesions to specific liver segments: utility of CT during arterial portography. Radiology (1990) 1.65
Hepatic resection of colorectal metastases. Influence of clinical factors and adjuvant intraperitoneal 5-fluorouracil via Tenckhoff catheter on survival. Ann Surg (1985) 1.65
Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation. Hum Pathol (1995) 1.64
Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16 E7-expressing tumors. Hum Gene Ther (1999) 1.63
The percutaneous needle biopsy is safe and recommended in the diagnosis of musculoskeletal masses. Cancer (2000) 1.61
Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer: results from a seroepidemiological case-control study. Obstet Gynecol (1997) 1.61
A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses. Verh Dtsch Ges Pathol (1997) 1.61
Lymphatic dissemination of hepatic metastases. Implications for the follow-up and treatment of patients with colorectal cancer. Cancer (1985) 1.61
Testing of diabetes-associated WFS1 polymorphisms in the Diabetes Prevention Program. Diabetologia (2007) 1.60
Villoglandular adenocarcinoma of the endometrium: a clinicopathologic study of 61 cases: a gynecologic oncology group study. Am J Surg Pathol (1998) 1.59
Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: a multi-institutional study. J Surg Oncol (2010) 1.59
Morbidity and mortality of cytoreductive surgery and intraperitoneal chemotherapy. Surgery (1993) 1.58
Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma. Am J Surg Pathol (1998) 1.58
Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma. A morphologically distinctive target for detection of Epstein-Barr virus in formalin-fixed paraffin-embedded carcinoma specimens. Am J Pathol (1991) 1.57
Immunohistochemical evidence supporting the appendiceal origin of pseudomyxoma peritonei in women. Int J Gynecol Pathol (1997) 1.55
A clinicopathologic analysis of atypical proliferative (borderline) tumors and well-differentiated endometrioid adenocarcinomas of the ovary. Am J Surg Pathol (2000) 1.54
Survival after induction chemotherapy and surgical resection for high-grade soft tissue sarcoma. Is radiation necessary? Ann Surg Oncol (2001) 1.53
A binary architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis. Am J Surg Pathol (2000) 1.51
Minimal uterine serous carcinoma: diagnosis and clinicopathologic correlation. Am J Surg Pathol (2000) 1.50
p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis. Hum Pathol (1995) 1.50
Endodermal sinus tumor of the ovary: a clinical and pathologic analysis of 71 cases. Cancer (1976) 1.49
Determinants of genital human papillomavirus infection in low-income women in Washington, D.C. Sex Transm Dis (1993) 1.48
The role of human papillomaviruses in the pathogenesis and histologic classification of precancerous lesions of the cervix. Hum Pathol (1986) 1.45
Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas. Am J Surg Pathol (1999) 1.45
Repeat hepatic resections for colorectal metastases. Surgery (1990) 1.45
Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans. Cancer Res (1981) 1.45
Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens. J Clin Microbiol (1997) 1.44
Serial carcinoembryonic antigen assays. Use in detection of cancer recurrence. JAMA (1974) 1.44
Trophoblastic pseudotumor of the uterus: an exaggerated form of "syncytial endometritis" simulating a malignant tumor. Cancer (1976) 1.43
Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40. Obstet Gynecol (1997) 1.42
Intramuscular administration of E7-transfected dendritic cells generates the most potent E7-specific anti-tumor immunity. Gene Ther (2000) 1.41
Prosthetic mesh repair of large hernias at the site of colonic stomas. Surg Gynecol Obstet (1980) 1.40
Antigen-specific immunotherapy for murine lung metastatic tumors expressing human papillomavirus type 16 E7 oncoprotein. Int J Cancer (1998) 1.38
Peritoneal approach to prosthetic mesh repair of paraostomy hernias. Ann Surg (1985) 1.36
A simplified plan for follow-up of patients with colon and rectal cancer supported by prospective studies of laboratory and radiologic test results. Surgery (1987) 1.35
Pseudomyxoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon. Ann Surg (1994) 1.35
Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features. Am J Surg Pathol (1992) 1.34
Surgery for colorectal cancer metastatic to the liver. Optimizing the results of treatment. Surg Clin North Am (1989) 1.33
Prospective, randomized trial of intravenous versus intraperitoneal 5-fluorouracil in patients with advanced primary colon or rectal cancer. Surgery (1985) 1.33
Evaluation of computed tomography in patients with peritoneal carcinomatosis. Cancer (1993) 1.29
Vaginal and cervical abnormalities after exposure to stilbestrol in utero. Obstet Gynecol (1972) 1.29
A serologically identified tumor antigen encoded by a homeobox gene promotes growth of ovarian epithelial cells. Proc Natl Acad Sci U S A (2001) 1.29
Giant cell tumor of the tendon sheath: MR findings in nine cases. AJR Am J Roentgenol (1994) 1.29
Patterns of serial CEA assays and their clinical use in management of colorectal cancer. J Surg Oncol (1976) 1.27